KaoKao Corporation4452東証プライム化学FY ending Dec 2025, consolidated, IFRS
About 43% of Kao's sales come from Global consumer care business, with Hygiene living care business and Health beauty care business making up much of the rest.
Out of every ¥100 of sales, about ¥10 is left as operating profit.
Revenue changed +3.7% from the prior year, operating profit +11.9%.
Revenue +3.7% · profit +11.9%, calculated from disclosed figures.
Operating leverage: 3.22× (profit growth ÷ revenue growth)
FY ending Dec 2024 → FY ending Dec 2025
Annual Securities Report, 120th fiscal period (Jan–Dec 2025) / 経営者による財政状態、経営成績及びキャッシュ・フローの状況の分析 · Annual Securities Report, 120th fiscal period (Jan–Dec 2025) / 事業等のリスク
FY ending Dec 2024 → FY ending Dec 2025
※ Segment revenues include inter-segment sales and are scaled to consolidated revenue
For every ¥100 Kao sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第120期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第119期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第118期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第117期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第116期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第115期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 44 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.